🍽️ tamoxifen citrate,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations   |   βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of tamoxifen citrate,(prescription) On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium longum Reduces
species Lacticaseibacillus paracasei Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by tamoxifen citrate,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
Mediterraneibacter genus Decreases 👪 Source Study
Coprococcus genus Decreases 👪 Source Study
Phocaeicola genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Lacrimispora genus Decreases 👪 Source Study
Agathobacter genus Decreases 👪 Source Study
Segatella genus Decreases 👪 Source Study
Collinsella genus Decreases 👪 Source Study proinflammatory
Lachnospira genus Decreases 👪 Source Study
Clostridioides genus Decreases 👪 Source Study
Dorea genus Decreases 👪 Source Study
Blautia genus Decreases 👪 Source Study
Clostridium genus Decreases 👪 Source Study Pathogen
Bifidobacterium genus Decreases 👪 Source Study
Lacticaseibacillus genus Decreases 👪 Source Study
Bacteroides genus Decreases 👪 Source Study
Thomasclavelia genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
Fusobacterium genus Decreases 👪 Source Study Periodontal disease, Lemierre syndrome, skin ulcers
Enterocloster genus Decreases 👪 Source Study
Odoribacter genus Decreases 👪 Source Study
Eggerthella genus Decreases 👪 Source Study
Bilophila genus Decreases 👪 Source Study High Level Cause Brain Fog(Cognitive impairment)
Akkermansia genus Decreases 👪 Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Eggerthellales order Decreases ⚗️ Source Study
Parabacteroides distasonis species Decreases 📓 Source Study
[Ruminococcus] gnavus species Decreases 📓 Source Study
Coprococcus comes species Decreases 📓 Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
Roseburia hominis species Decreases 📓 Source Study
[Ruminococcus] torques species Decreases 📓 Source Study
Parabacteroides merdae species Decreases 📓 Source Study Infectious bacteria
Roseburia intestinalis species Decreases 📓 Source Study
Lacrimispora saccharolytica species Decreases 📓 Source Study
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Agathobacter rectalis species Decreases 📓 Source Study
Segatella copri species Decreases 📓 Source Study Over 70%ile Indicator of mycotoxin present
Bacteroides uniformis species Decreases 📓 Source Study Infectious bacteria
Collinsella aerofaciens species Decreases 📓 Source Study
Lachnospira eligens species Decreases 📓 Source Study
Bacteroides thetaiotaomicron species Decreases 📓 Source Study
Clostridioides difficile species Decreases 📓 Source Study Colitis
Bacteroides fragilis species Decreases 📓 Source Study H02076 Bacteroides infection
Bifidobacterium longum species Decreases 📓 Source Study
Dorea formicigenerans species Decreases 📓 Source Study
Blautia obeum species Decreases 📓 Source Study
Clostridium perfringens species Decreases 📓 Source Study Food poisoning, gas gangrene
Lacticaseibacillus paracasei species Decreases 📓 Source Study
Bifidobacterium adolescentis species Decreases 📓 Source Study
Thomasclavelia ramosa species Decreases 📓 Source Study
Fusobacterium nucleatum species Decreases 📓 Source Study Infectious bacteria
Bacteroides ovatus species Decreases 📓 Source Study
Enterocloster bolteae species Decreases 📓 Source Study
Streptococcus parasanguinis species Decreases 📓 Source Study
Odoribacter splanchnicus species Decreases 📓 Source Study
Staphylococcus aureus species Decreases 📓 Source Study Skin infections, sinusitis, food poisoning
Eggerthella lenta species Decreases 📓 Source Study
Bilophila wadsworthia species Decreases 📓 Source Study
Bacteroides xylanisolvens species Decreases 📓 Source Study
Akkermansia muciniphila species Decreases 📓 Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Allisonella histaminiformans species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Bifidobacterium longum subsp. infantis subspecies Decreases 👶 Source Study
Bifidobacterium longum subsp. longum subspecies Decreases 👶 Source Study
Bifidobacterium longum subsp. suillum subspecies Decreases 👶 Source Study
Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases 👶 Source Study
Fusobacterium nucleatum subsp. nucleatum subspecies Decreases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of tamoxifen citrate,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.2 0.2
Acne 0.4 -0.4
ADHD 6.1 0.7 7.71
Age-Related Macular Degeneration and Glaucoma 1 0.5 1
Allergic Rhinitis (Hay Fever) 2.4 2.2 0.09
Allergies 6.1 3 1.03
Allergy to milk products 0.9 0.9 0
Alopecia (Hair Loss) 2.5 2.5
Alzheimer's disease 4.2 8.1 -0.93
Amyotrophic lateral sclerosis (ALS) Motor Neuron 4.1 0.3 12.67
Ankylosing spondylitis 4.3 2.3 0.87
Anorexia Nervosa 0.5 2.8 -4.6
Antiphospholipid syndrome (APS) 2.4 0.2 11
Asthma 1.9 1.8 0.06
Atherosclerosis 1.3 2.6 -1
Atrial fibrillation 4.2 2.5 0.68
Autism 12.3 12 0.03
Barrett esophagus cancer 0.4 0.4 0
Bipolar Disorder 1.1 1.2 -0.09
Brain Trauma 0.9 0.9 0
Carcinoma 3.9 3.1 0.26
Celiac Disease 2.1 4.4 -1.1
Cerebral Palsy 1.4 1.4 0
Chronic Fatigue Syndrome 6.4 8.7 -0.36
Chronic Kidney Disease 3.1 3 0.03
Chronic Lyme 0.9 -0.9
Chronic Obstructive Pulmonary Disease (COPD) 2.3 1.5 0.53
Chronic Urticaria (Hives) 0.9 2.2 -1.44
Coagulation / Micro clot triggering bacteria 1.4 1.4 0
Colorectal Cancer 5.2 1.4 2.71
Constipation 1.9 1 0.9
Coronary artery disease 2 1 1
COVID-19 13.6 17.6 -0.29
Crohn's Disease 9.2 8.1 0.14
cystic fibrosis 1.3 -1.3
deep vein thrombosis 0.5 0.9 -0.8
Depression 12.2 10.9 0.12
Dermatomyositis 0.4 0.4 0
Eczema 1 3.3 -2.3
Endometriosis 3.2 0.8 3
Eosinophilic Esophagitis 0.4 0.4
Epilepsy 3.7 3.2 0.16
Fibromyalgia 4.2 4.3 -0.02
Functional constipation / chronic idiopathic constipation 7.5 5.3 0.42
gallstone disease (gsd) 1.9 1.3 0.46
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 2.4 1.4 0.71
Generalized anxiety disorder 1.9 2.8 -0.47
giant cell arteritis 0.5 -0.5
Glioblastoma 0.4 -0.4
Gout 0.5 -0.5
Graves' disease 1.8 2 -0.11
Halitosis 0.8 0.4 1
Hashimoto's thyroiditis 3.5 1 2.5
Hidradenitis Suppurativa 0.9 0.9
Histamine Issues,Mast Cell Issue, DAO Insufficiency 4.2 1.5 1.8
hypercholesterolemia (High Cholesterol) 0.7 0.3 1.33
hyperglycemia 2.2 -2.2
Hyperlipidemia (High Blood Fats) 1.1 0.5 1.2
hypersomnia 0.6 -0.6
hypertension (High Blood Pressure 2.4 6.6 -1.75
Hypothyroidism 1.7 -1.7
Hypoxia 1 1
IgA nephropathy (IgAN) 6.6 -6.6
Inflammatory Bowel Disease 5.8 11.1 -0.91
Insomnia 1.3 1.4 -0.08
Intelligence 2 1 1
Intracranial aneurysms 1.4 0.5 1.8
Irritable Bowel Syndrome 3.1 5.3 -0.71
Liver Cirrhosis 5.6 3.5 0.6
Long COVID 10.2 11.4 -0.12
Low bone mineral density 1.5 -1.5
Lung Cancer 1.2 -1.2
ME/CFS with IBS 1.6 3.8 -1.37
ME/CFS without IBS 2.7 3.3 -0.22
Menopause 2.5 2.5
Metabolic Syndrome 8.8 11.5 -0.31
Mood Disorders 14.5 11.1 0.31
multiple chemical sensitivity [MCS] 1.5 0.5 2
Multiple Sclerosis 6.5 8.1 -0.25
Multiple system atrophy (MSA) 1.9 0.9 1.11
Neuropathy (all types) 1 1
neuropsychiatric disorders (PANDAS, PANS) 0.3 0.3
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 3.3 6.6 -1
NonCeliac Gluten Sensitivity 0.4 -0.4
Obesity 10.5 6.2 0.69
obsessive-compulsive disorder 7.5 6.3 0.19
Osteoarthritis 3.1 3.1
Osteoporosis 1.1 1.1 0
pancreatic cancer 0.7 0.7
Parkinson's Disease 3.1 5.2 -0.68
Polycystic ovary syndrome 2.8 1.8 0.56
Postural orthostatic tachycardia syndrome 0.5 0.9 -0.8
Premenstrual dysphoric disorder 1.4 0.5 1.8
primary biliary cholangitis 0.5 1.5 -2
Psoriasis 5.4 4.2 0.29
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 9 4.9 0.84
Rosacea 1.4 1 0.4
Schizophrenia 7.9 2.4 2.29
scoliosis 0.5 1.2 -1.4
Sjögren syndrome 2.6 4.6 -0.77
Sleep Apnea 1.8 2.1 -0.17
Small Intestinal Bacterial Overgrowth (SIBO) 0.8 1 -0.25
Stress / posttraumatic stress disorder 3.3 3.1 0.06
Systemic Lupus Erythematosus 5.3 2.2 1.41
Tic Disorder 1.3 2.5 -0.92
Tourette syndrome 0.1 0.4 -3
Type 1 Diabetes 4.3 3.7 0.16
Type 2 Diabetes 9.4 9.2 0.02
Ulcerative colitis 3.1 7.4 -1.39
Unhealthy Ageing 8.5 2.8 2.04

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)